News & Events

Back Home
Previous | NextPages2 3 4 5 6 7 8  Next >> [63]
  • November 24, 2014

    MYOS Corporation announced the closing of their registered direct offering in the amount of $1.81 million.  EG&S acted as counsel to MYOS Corporation.

  • October 29, 2014

    Hydra Industries Acquisition Corp. (NASDAQ: HDRAU) announced the closing of its initial public offering in the amount of $80,000,000.  EG&S acted as counsel to Hydra Industries.

  • October 22, 2014

    Orlando Bathing Suit LLC, a national retailer of swimsuits under the trade name Everything But Water, acquired Aqua Beachwear, a Florida based swimsuit retailer. EG&S acted as counsel to Orlando Bathing Suit in this transaction.

  • October 14, 2014

    International Stem Cell Corporation announced the closing of their PIPE offering in the amount of $2,500,000.  EG&S acted as counsel to the Placement Agent.

  • October 10, 2014

    Cytori Therapeutics, Inc. announced the closing of their Registered Direct offering in the amount of $13,500,000.  EG&S acted as counsel to the Investor.

  • October 10, 2014

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for Q3 2014.

    Click here to view the rankings

  • October 6, 2014

    DT Asia Investments Limited announced the completion of their IPO in the amount of $60,000,000.  EG&S acted as counsel to DT Asia.

  • September 29, 2014

    Lpath, Inc. announced the closing of its previously announced $12.5 million registered direct offering. Lpath sold registered shares of common stock and warrants to purchase unregistered shares of common stock in a registered direct offering. EG&S acted as counsel to the placement agent.

  • September 24, 2014

    Baxano Surgical, Inc. announced the closing of their Registered Direct offering in the amount of $1,384,801.  EG&S acted as counsel to the Investor.

  • September 23, 2014

    LabStyle Innovations Corp. (OTCQB:DRIO) announced the closing of a $4.2 million private placement consisting of preferred stock and warrants. EG&S acted as counsel to LabStyle. 

Previous | NextPages2 3 4 5 6 7 8  Next >> [63]
?